Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2026 Filed May 5, 2026 20:27 UTC |
Aunan Greg DChief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,372 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-030622 · wk-form4_1778012858.xml · derivative · entry 4 Aunan Greg D · CIK 0001646370 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,745 Underlying: Common Stock · 5,372 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On May 2, 2024, Mr. Aunan was granted 16,117 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. F6 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| May 02, 2026 Filed May 5, 2026 20:27 UTC |
Aunan Greg DChief Accounting Officer
|
Tax withholdingCommon Stock | 1,309 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-030622 · wk-form4_1778012858.xml · nonDerivative · entry 3 Aunan Greg D · CIK 0001646370 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,153 F4 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. Read SEC document |
| May 02, 2026 Filed May 5, 2026 20:27 UTC |
Aunan Greg DChief Accounting Officer
|
Exercise / conversionCommon Stock | 5,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-030622 · wk-form4_1778012858.xml · nonDerivative · entry 2 Aunan Greg D · CIK 0001646370 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Reflects the release of restricted stock units that were previously reported on a Form 4. F3 · price: Each restricted stock unit is economic equivalent of one share of NeoGenomics, Inc. common stock and is converted into common stock upon vesting. Read SEC document |
| May 02, 2026 Filed May 5, 2026 20:26 UTC |
Stone WarrenPres & Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,969 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-030619 · wk-form4_1778012808.xml · derivative · entry 3 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,939 Underlying: Common Stock · 5,969 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On May 2, 2024, Mr. Stone was granted 17,905 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. F5 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| May 02, 2026 Filed May 5, 2026 20:26 UTC |
Stone WarrenPres & Chief Operating Officer
|
Tax withholdingCommon Stock | 2,349 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-030619 · wk-form4_1778012808.xml · nonDerivative · entry 2 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,985 F3 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. Read SEC document |
| May 02, 2026 Filed May 5, 2026 20:26 UTC |
Stone WarrenPres & Chief Operating Officer
|
Exercise / conversionCommon Stock | 5,969 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-030619 · wk-form4_1778012808.xml · nonDerivative · entry 1 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects the release of restricted stock units that were previously reported on a Form 4. F2 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics, Inc. common stock and is converted into common stock upon vesting. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:27 UTC |
Aunan Greg DChief Accounting Officer
|
Tax withholdingCommon Stock | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-030622 · wk-form4_1778012858.xml · nonDerivative · entry 1 Aunan Greg D · CIK 0001646370 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,090 F1 · shares: Shares surrendered to NeoGenomics, Inc. for retirement to satisfy tax obligations in connection with the May 1, 2026 vesting of restricted stock. Read SEC document |
| May 01, 2026 Filed May 5, 2026 20:27 UTC |
Olivo Alicia CEVP, GC & Business Development
|
Tax withholdingCommon Stock | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-030621 · wk-form4_1778012834.xml · nonDerivative · entry 1 Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,182 Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:39 UTC |
Stone WarrenPres & Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 17,562 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023691 · wk-form4_1775248747.xml · derivative · entry 3 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,125 Underlying: Common Stock · 17,562 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 1, 2025, Mr. Stone was granted 52,687 restricted stock units. The restricted stock units vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grant date. F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:39 UTC |
Stone WarrenPres & Chief Operating Officer
|
Tax withholdingCommon Stock | 6,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023691 · wk-form4_1775248747.xml · nonDerivative · entry 2 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,365 Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:39 UTC |
Stone WarrenPres & Chief Operating Officer
|
Exercise / conversionCommon Stock | 17,562 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023691 · wk-form4_1775248747.xml · nonDerivative · entry 1 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:38 UTC |
Zook Anthony P.Director · Chief Executive Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 140,498 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023689 · wk-form4_1775248724.xml · derivative · entry 4 Zook Anthony P. · CIK 0001582393 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,998 Underlying: Common Stock · 140,498 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. F2 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:38 UTC |
Zook Anthony P.Director · Chief Executive Officer
|
Tax withholdingCommon Stock | 45,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023689 · wk-form4_1775248724.xml · nonDerivative · entry 2 Zook Anthony P. · CIK 0001582393 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,111 Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 20:38 UTC |
Zook Anthony P.Director · Chief Executive Officer
|
Exercise / conversionCommon Stock | 140,498 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023689 · wk-form4_1775248724.xml · nonDerivative · entry 1 Zook Anthony P. · CIK 0001582393 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:16 UTC |
Aunan Greg DChief Accounting Officer
|
GrantRestricted Stock Unit · Derivative | 22,889 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-014150 · wk-form4_1772579799.xml · derivative · entry 3 Aunan Greg D · CIK 0001646370 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,889 Underlying: Common Stock · 22,889 shares Expires not disclosed F2 · derivative.exercise_date: On March 1, 2026, Mr. Aunan was granted 22,889 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. F3 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:16 UTC |
Aunan Greg DChief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 36,825 | $0.00 Strike: $9.83 | $0.00 |
DisclosureSEC source: 0001628280-26-014150 · wk-form4_1772579799.xml · derivative · entry 2 Aunan Greg D · CIK 0001646370 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,825 Underlying: Common Stock · 36,825 shares Expires 2036-03-01 F1 · derivative.exercise_date: On March 1, 2026, Mr. Aunan was granted 36,825 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:16 UTC |
Olivo Alicia CEVP, GC & Business Development
|
GrantRestricted Stock Unit · Derivative | 89,013 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-014149 · wk-form4_1772579782.xml · derivative · entry 3 Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,013 Underlying: Common Stock · 89,013 shares Expires not disclosed F3 · derivative.exercise_date: On March 1, 2026, Ms. Olivo was granted 89,013 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:16 UTC |
Olivo Alicia CEVP, GC & Business Development
|
GrantStock Option (Right to Buy) · Derivative | 147,804 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001628280-26-014149 · wk-form4_1772579782.xml · derivative · entry 2 Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,804 Underlying: Common Stock · 147,804 shares Expires 2036-03-01 F1 · derivative.exercise_price: This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 and multiplied by 110%. F2 · derivative.exercise_date: On March 1, 2026, Ms. Olivo was granted 147,804 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:16 UTC |
Stone WarrenPres & Chief Operating Officer
|
GrantRestricted Stock Unit · Derivative | 152,594 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-014147 · wk-form4_1772579762.xml · derivative · entry 3 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,594 Underlying: Common Stock · 152,594 shares Expires not disclosed F3 · derivative.exercise_date: On March 1, 2026, Mr. Stone was granted 152,594 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:16 UTC |
Stone WarrenPres & Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 253,378 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001628280-26-014147 · wk-form4_1772579762.xml · derivative · entry 2 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,378 Underlying: Common Stock · 253,378 shares Expires 2036-03-01 F1 · derivative.exercise_price: This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 multiplied by 110%. F2 · derivative.exercise_date: On March 1, 2026, Mr. Stone was granted 253,378 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:15 UTC |
Zook Anthony P.Director · Chief Executive Officer
|
GrantRestricted Stock Unit · Derivative | 406,918 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-014146 · wk-form4_1772579744.xml · derivative · entry 4 Zook Anthony P. · CIK 0001582393 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406,918 Underlying: Common Stock · 406,918 shares Expires not disclosed F3 · derivative.exercise_date: On March 1, 2026, Mr. Zook was granted 406,918 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 23:15 UTC |
Zook Anthony P.Director · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 675,676 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001628280-26-014146 · wk-form4_1772579744.xml · derivative · entry 3 Zook Anthony P. · CIK 0001582393 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 675,676 Underlying: Common Stock · 675,676 shares Expires 2036-03-01 F1 · derivative.exercise_price: This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 and multiplied by 110%. F2 · derivative.exercise_date: On March 1, 2026, Mr. Zook was granted 675,676 stock options. The options vest ratably over the first three anniversary dates of the grant date. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:15 UTC |
Stone WarrenPres & Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,443 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011102 · wk-form4_1771967722.xml · derivative · entry 6 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,443 Underlying: Common Stock · 8,443 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On February 23, 2024, Mr. Stone was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:15 UTC |
Stone WarrenPres & Chief Operating Officer
|
Tax withholdingCommon Stock | 3,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011102 · wk-form4_1771967722.xml · nonDerivative · entry 4 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,714 F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:15 UTC |
Stone WarrenPres & Chief Operating Officer
|
Exercise / conversionCommon Stock | 8,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011102 · wk-form4_1771967722.xml · nonDerivative · entry 3 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:15 UTC |
Sherman Jeffrey ScottChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 15,535 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011099 · wk-form4_1771967703.xml · derivative · entry 6 Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,536 Underlying: Common Stock · 15,535 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: On February 23, 2024, Mr. Sherman was granted 46,606 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. F5 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:15 UTC |
Sherman Jeffrey ScottChief Financial Officer
|
Tax withholdingCommon Stock | 3,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011099 · wk-form4_1771967703.xml · nonDerivative · entry 4 Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,009 F3 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:15 UTC |
Sherman Jeffrey ScottChief Financial Officer
|
Exercise / conversionCommon Stock | 15,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011099 · wk-form4_1771967703.xml · nonDerivative · entry 3 Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,792 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:14 UTC |
Olivo Alicia CEVP, GC & Business Development
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,443 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011097 · wk-form4_1771967680.xml · derivative · entry 6 Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,443 Underlying: Common Stock · 8,443 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: On February 23, 2024, Ms. Olivo was granted 25,329 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:14 UTC |
Olivo Alicia CEVP, GC & Business Development
|
Tax withholdingCommon Stock | 3,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011097 · wk-form4_1771967680.xml · nonDerivative · entry 4 Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,224 F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. Read SEC document |
| February 23, 2026 Filed Feb 24, 2026 21:14 UTC |
Olivo Alicia CEVP, GC & Business Development
|
Exercise / conversionCommon Stock | 8,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011097 · wk-form4_1771967680.xml · nonDerivative · entry 3 Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:15 UTC |
Stone WarrenPres & Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 28,105 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011102 · wk-form4_1771967722.xml · derivative · entry 5 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,212 Underlying: Common Stock · 28,105 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On February 21, 2025, Mr. Stone was granted 84,317 restricted stock units. At the time of the grant, the restricted stock units vested ratably over the first three anniversary dates of the grant date. In connection with Mr. Stone'spromotion to President & Chief Operating Officer on April 1, 2025, the vesting schedule of these restricted stock units was modified so that they now vest ratably on the 12-month, 18-month and 24-month anniversary dates of the grantdate. F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:15 UTC |
Stone WarrenPres & Chief Operating Officer
|
Tax withholdingCommon Stock | 7,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011102 · wk-form4_1771967722.xml · nonDerivative · entry 2 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,594 F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:15 UTC |
Stone WarrenPres & Chief Operating Officer
|
Exercise / conversionCommon Stock | 28,105 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011102 · wk-form4_1771967722.xml · nonDerivative · entry 1 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,736 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:15 UTC |
Sherman Jeffrey ScottChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 42,158 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011099 · wk-form4_1771967703.xml · derivative · entry 5 Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,318 Underlying: Common Stock · 42,158 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On February 21, 2025, Mr. Sherman was granted 126,476 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. F5 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:15 UTC |
Sherman Jeffrey ScottChief Financial Officer
|
Tax withholdingCommon Stock | 10,729 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011099 · wk-form4_1771967703.xml · nonDerivative · entry 2 Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,257 F3 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:15 UTC |
Sherman Jeffrey ScottChief Financial Officer
|
Exercise / conversionCommon Stock | 42,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011099 · wk-form4_1771967703.xml · nonDerivative · entry 1 Sherman Jeffrey Scott · CIK 0001463145 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting. F2 · balance_after: This balance includes 434 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan. The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:14 UTC |
Aunan Greg DChief Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,323 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011095 · wk-form4_1771967656.xml · derivative · entry 3 Aunan Greg D · CIK 0001646370 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,648 Underlying: Common Stock · 6,323 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On February 21, 2025, Mr. Aunan was granted 18,971 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:14 UTC |
Aunan Greg DChief Accounting Officer
|
Tax withholdingCommon Stock | 1,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011095 · wk-form4_1771967656.xml · nonDerivative · entry 2 Aunan Greg D · CIK 0001646370 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,027 F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:14 UTC |
Aunan Greg DChief Accounting Officer
|
Exercise / conversionCommon Stock | 6,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011095 · wk-form4_1771967656.xml · nonDerivative · entry 1 Aunan Greg D · CIK 0001646370 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:14 UTC |
Olivo Alicia CEVP, GC & Business Development
|
Exercise / conversionRestricted Stock Unit · Derivative | 21,079 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011097 · wk-form4_1771967680.xml · derivative · entry 5 Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,159 Underlying: Common Stock · 21,079 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On February 21, 2025, Ms. Olivo was granted 63,238 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. F4 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:14 UTC |
Olivo Alicia CEVP, GC & Business Development
|
Tax withholdingCommon Stock | 8,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011097 · wk-form4_1771967680.xml · nonDerivative · entry 2 Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,104 F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. Read SEC document |
| February 21, 2026 Filed Feb 24, 2026 21:14 UTC |
Olivo Alicia CEVP, GC & Business Development
|
Exercise / conversionCommon Stock | 21,079 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011097 · wk-form4_1771967680.xml · nonDerivative · entry 1 Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,399 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting. Read SEC document |
| January 20, 2026 Filed Jan 22, 2026 02:01 UTC |
Stone WarrenPres & Chief Operating Officer
|
SaleCommon Stock | 22,128 | $12.50 | $276,681.87 |
DisclosureSEC source: 0001628280-26-002970 · wk-form4_1769047301.xml · nonDerivative · entry 1 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 121,631 Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 21:22 UTC |
Olivo Alicia CEVP, GC & Business Development
|
Tax withholdingCommon Stock | 15,145 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002198 · wk-form4_1768512125.xml · nonDerivative · entry 2 Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,320 F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 21:22 UTC |
Olivo Alicia CEVP, GC & Business Development
|
Exercise / conversionCommon Stock | 59,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002198 · wk-form4_1768512125.xml · nonDerivative · entry 1 Olivo Alicia C · CIK 0001951869 · EVP, GC & Business Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,465 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 21:22 UTC |
Stone WarrenPres & Chief Operating Officer
|
Tax withholdingCommon Stock | 15,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002199 · wk-form4_1768512161.xml · nonDerivative · entry 2 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,759 F2 · shares: Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 21:22 UTC |
Stone WarrenPres & Chief Operating Officer
|
Exercise / conversionCommon Stock | 59,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-002199 · wk-form4_1768512161.xml · nonDerivative · entry 1 Stone Warren · CIK 0001955295 · Pres & Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:15 UTC |
Kenny John P.Director
|
GrantRestricted Stock Unit · Derivative | 5,893 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-000706 · wk-form4_1767654937.xml · derivative · entry 2 Kenny John P. · CIK 0001719325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,893 Underlying: Common Stock · 5,893 shares Expires not disclosed F1 · derivative.expiration_date: Once vested, the shares of common stock are not subject to expiration. Read SEC document |
| January 01, 2026 Filed Jan 5, 2026 23:15 UTC |
Kenny John P.Director
|
GrantStock Option (Right to Buy) · Derivative | 4,171 | $0.00 Strike: $11.76 | $0.00 |
DisclosureSEC source: 0001628280-26-000706 · wk-form4_1767654937.xml · derivative · entry 1 Kenny John P. · CIK 0001719325 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,171 Underlying: Common Stock · 4,171 shares Expires 2036-01-01 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.